Telman Deborah H, EVP of Corporate Affairs and General Counsel at Gilead Sciences ($GILD), sold about $6.6 million in company shares across three open market transactions over the past year. Her most recent sale occurred on November 12, 2025. These sales rank her 1,572nd among 11,678 individual insiders by total value sold, below the average of $8.6 million per insider and 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | S | Common Stock | 17181 | $124.00 | 43,676.0000 | 1,256,000,000 | 28.23% | 0.00% |
| Nov. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 35965 | $60.75 | 79,641.0000 | 1,256,000,000 | 82.34% | 0.00% |
| Nov. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | S | Common Stock | 35965 | $122.30 | 43,676.0000 | 1,256,000,000 | 45.16% | 0.00% |
| Nov. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Non-qualified Stock Option (Right to Buy) | 17181 | $0.00 | 37,799.0000 | 1,256,000,000 | 31.25% | 0.00% |
| Nov. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | S | Common Stock | 500 | $122.90 | 43,676.0000 | 1,256,000,000 | 1.13% | 0.00% |
| Nov. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Non-qualified Stock Option (Right to Buy) | 35965 | $0.00 | 12,655.0000 | 1,256,000,000 | 73.97% | 0.00% |
| Nov. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 500 | $60.75 | 44,176.0000 | 1,256,000,000 | 1.14% | 0.00% |
| Nov. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 17181 | $75.12 | 60,857.0000 | 1,256,000,000 | 39.34% | 0.00% |
| Nov. 12, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Non-qualified Stock Option (Right to Buy) | 500 | $0.00 | 12,155.0000 | 1,256,000,000 | 3.95% | 0.00% |
| Oct. 25, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 241 | $120.94 | 43,676.0000 | 1,256,000,000 | 0.55% | 0.00% |
| Oct. 25, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 515 | $0.00 | 43,917.0000 | 1,256,000,000 | 1.19% | 0.00% |
| Oct. 25, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 515 | $0.00 | 19,816.0000 | 1,256,000,000 | 2.53% | 0.00% |
| Sept. 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 1315 | $0.00 | 44,036.0000 | 1,255,000,000 | 3.08% | 0.00% |
| Sept. 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 1315 | $0.00 | 20,331.0000 | 1,255,000,000 | 6.08% | 0.00% |
| Sept. 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 634 | $115.25 | 43,402.0000 | 1,255,000,000 | 1.44% | 0.00% |
| July 25, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 514 | $0.00 | 38,315.0000 | 1,255,000,000 | 1.36% | 0.00% |
| July 25, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 8229 | $0.00 | 21,646.0000 | 1,255,000,000 | 27.54% | 0.00% |
| July 25, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 514 | $0.00 | 29,875.0000 | 1,255,000,000 | 1.69% | 0.00% |
| July 25, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 8229 | $0.00 | 46,544.0000 | 1,255,000,000 | 21.48% | 0.00% |
| July 25, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 3823 | $116.20 | 42,721.0000 | 1,255,000,000 | 8.21% | 0.00% |
| June 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 430 | $110.09 | 37,801.0000 | 1,255,000,000 | 1.12% | 0.00% |
| June 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 1313 | $0.00 | 38,231.0000 | 1,255,000,000 | 3.56% | 0.00% |
| June 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 1313 | $0.00 | 30,389.0000 | 1,255,000,000 | 4.14% | 0.00% |
| May 19, 2025 | AtriCure, Inc. | $ATRC | Telman Deborah H | Director | A | Common Stock | 5401 | $0.00 | 22,184.0000 | 48,879,604 | 32.18% | 0.01% |
| April 25, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 514 | $0.00 | 37,076.0000 | 1,255,000,000 | 1.41% | 0.00% |
| April 25, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 158 | $103.17 | 36,918.0000 | 1,255,000,000 | 0.43% | 0.00% |
| April 25, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 514 | $0.00 | 31,702.0000 | 1,255,000,000 | 1.60% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | A | Non-qualified Stock Option (Right to Buy) | 33940 | $0.00 | 33,940.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | A | Restricted Stock Unit | 7680 | $0.00 | 32,216.0000 | 1,255,000,000 | 31.30% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 3343 | $0.00 | 37,692.0000 | 1,255,000,000 | 9.73% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 1130 | $117.21 | 36,562.0000 | 1,255,000,000 | 3.00% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 3343 | $0.00 | 24,356.0000 | 1,255,000,000 | 12.07% | 0.00% |
| Feb. 4, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | A | Common Stock | 12371 | $0.00 | 34,011.0000 | 1,255,000,000 | 57.17% | 0.00% |
| Jan. 25, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 187 | $93.07 | 21,640.0000 | 1,255,000,000 | 0.86% | 0.00% |
| Jan. 25, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 515 | $0.00 | 21,827.0000 | 1,255,000,000 | 2.42% | 0.00% |
| Jan. 25, 2025 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 515 | $0.00 | 27,879.0000 | 1,255,000,000 | 1.81% | 0.00% |
| Dec. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 306 | $92.34 | 21,312.0000 | 1,254,000,000 | 1.42% | 0.00% |
| Dec. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 639 | $0.00 | 28,394.0000 | 1,254,000,000 | 2.20% | 0.00% |
| Dec. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 639 | $0.00 | 21,618.0000 | 1,254,000,000 | 3.05% | 0.00% |
| Oct. 25, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 242 | $89.00 | 20,979.0000 | 1,254,000,000 | 1.14% | 0.00% |
| Oct. 25, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 514 | $0.00 | 29,033.0000 | 1,254,000,000 | 1.74% | 0.00% |
| Oct. 25, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 514 | $0.00 | 21,221.0000 | 1,254,000,000 | 2.48% | 0.00% |
| Sept. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 639 | $0.00 | 21,014.0000 | 1,258,000,000 | 3.14% | 0.00% |
| Sept. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 639 | $0.00 | 29,547.0000 | 1,258,000,000 | 2.12% | 0.00% |
| Sept. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 307 | $81.44 | 20,707.0000 | 1,258,000,000 | 1.46% | 0.00% |
| July 25, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 8230 | $0.00 | 20,375.0000 | 1,258,000,000 | 67.76% | 0.00% |
| July 25, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 514 | $0.00 | 12,145.0000 | 1,258,000,000 | 4.42% | 0.00% |
| July 25, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 2917 | $76.51 | 11,631.0000 | 1,258,000,000 | 20.05% | 0.00% |
| July 25, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 8230 | $0.00 | 30,186.0000 | 1,258,000,000 | 21.42% | 0.00% |
| July 25, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 514 | $0.00 | 38,416.0000 | 1,258,000,000 | 1.32% | 0.00% |
| June 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 204 | $65.25 | 14,548.0000 | 1,258,000,000 | 1.38% | 0.00% |
| June 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 638 | $0.00 | 14,752.0000 | 1,258,000,000 | 4.52% | 0.00% |
| June 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 638 | $0.00 | 38,930.0000 | 1,258,000,000 | 1.61% | 0.00% |
| May 13, 2024 | AtriCure, Inc. | $ATRC | Telman Deborah H | Director | A | Common Stock | 7788 | $0.00 | 16,783.0000 | 0 | 86.58% | 0.00% |
| April 25, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 515 | $0.00 | 39,568.0000 | 1,258,000,000 | 1.28% | 0.00% |
| April 25, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 515 | $0.00 | 14,272.0000 | 1,258,000,000 | 3.74% | 0.00% |
| April 25, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 158 | $65.27 | 14,114.0000 | 1,258,000,000 | 1.11% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 2555 | $0.00 | 14,603.0000 | 1,258,000,000 | 21.21% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | A | Restricted Stock Unit | 10815 | $0.00 | 40,083.0000 | 1,258,000,000 | 36.95% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | A | Non-qualified Stock Option (Right to Buy) | 54980 | $0.00 | 54,980.0000 | 1,258,000,000 | 9999.99% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 2555 | $0.00 | 29,268.0000 | 1,258,000,000 | 8.03% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 846 | $75.12 | 13,757.0000 | 1,258,000,000 | 5.79% | 0.00% |
| Jan. 31, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | A | Common Stock | 4646 | $0.00 | 11,728.0000 | 1,258,000,000 | 65.60% | 0.00% |
| Jan. 25, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 514 | $0.00 | 31,823.0000 | 1,258,000,000 | 1.59% | 0.00% |
| Jan. 25, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 514 | $0.00 | 7,276.0000 | 1,258,000,000 | 7.60% | 0.00% |
| Jan. 25, 2024 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 194 | $80.23 | 7,082.0000 | 1,258,000,000 | 2.67% | 0.00% |
| Oct. 25, 2023 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 243 | $78.39 | 6,762.0000 | 1,262,000,000 | 3.47% | 0.00% |
| Oct. 25, 2023 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 514 | $0.00 | 7,005.0000 | 1,262,000,000 | 7.92% | 0.00% |
| Oct. 25, 2023 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 514 | $0.00 | 32,337.0000 | 1,262,000,000 | 1.56% | 0.00% |
| July 25, 2023 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 8231 | $0.00 | 8,607.0000 | 1,262,000,000 | 2189.10% | 0.00% |
| July 25, 2023 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | F | Common Stock | 4174 | $77.23 | 4,433.0000 | 1,262,000,000 | 48.50% | 0.00% |
| July 25, 2023 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Common Stock | 2058 | $0.00 | 6,491.0000 | 1,262,000,000 | 46.42% | 0.00% |
| July 25, 2023 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 8231 | $0.00 | 34,909.0000 | 1,262,000,000 | 19.08% | 0.00% |
| July 25, 2023 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | M | Restricted Stock Unit | 2058 | $0.00 | 32,851.0000 | 1,262,000,000 | 5.90% | 0.00% |
| May 25, 2023 | AtriCure, Inc. | $ATRC | Telman Deborah H | Director | A | Common Stock | 3186 | $0.00 | 8,995.0000 | 0 | 54.85% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | A | Restricted Stock Unit | 10220 | $0.00 | 43,140.0000 | 1,262,000,000 | 31.04% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | A | Non-qualified Stock Option (Right to Buy) | 46605 | $0.00 | 46,605.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| Feb. 15, 2023 | GILEAD SCIENCES, INC. | $GILD | Telman Deborah H | EVP, Corporate Affairs & GC | A | Common Stock | 376 | $56.38 | 376.0000 | 1,262,000,000 | 9999.99% | 0.00% |